Close R&D credit deals with new OBBBA rules in 2026

The One Big Beautiful Bill Act restored the deductibility of immediate domestic R&D expenses for tax years beginning after the effective date, reversing one of the most damaging provisions that required businesses to capitalize and amortize domestic research costs over 5 years. For tax advisors, this restoration creates a powerful and time-sensitive sales opportunity. Businesses that struggled under the capitalization rules from 2022 through 2024 can now immediately expense qualifying domestic research costs again, and many of them have no idea the rules have changed. Finding those businesses and explaining the financial impact of the change is the foundation of every R&D credit advisory deal you will close in 2026.

The R&D tax credit itself, formalized under Section 41 of the Internal Revenue Code, has always been one of the most underutilized incentives in the tax code. Most business owners either do not know they qualify, believe the credit is only for pharmaceutical or technology companies, or have heard it is complicated and not worth the effort. Your job as an advisor is to dismantle each of these misconceptions and replace them with a clear picture of the dollars available to them through proper tax advisory services.

What the OBBBA changed for R&D advisory sales in 2026

Before the OBBBA, domestic R&D expenses had to be capitalized and amortized over five years for tax years beginning after December 31, 2021. That rule transformed an immediate cash-flow benefit into a slow deduction that many businesses found difficult to track and frustrating to explain to clients. The OBBBA restores the immediate deduction for domestic research and development spending, which dramatically improves the cash-flow impact and makes the strategy far more compelling in a client presentation.

Foreign R&D expenses still require 15-year amortization, a distinction that matters for businesses with offshore development operations. When presenting AI-driven R&D tax credits to prospects, your pitch should lead with the domestic restoration news because it represents the largest practical change for most clients.

Businesses that paid taxes on research costs they should have been able to deduct immediately from 2022 through 2024 also have a retroactive relief pathway under Revenue Procedure 2025-28. Clients who qualify for this retroactive election can file amended returns or superseding returns to recover taxes paid on capitalized R&D costs. That potential refund is one of the most compelling opening lines in a sales conversation: "You may be owed a refund for research costs your business expensed between 2022 and 2024."

How to identify your best R&D credit prospects

The R&D tax credit is broader than most business owners realize. It applies to any business that develops, improves, or tests products, processes, software, techniques, formulas, or inventions. That definition covers a remarkably wide range of industries.

• Manufacturing companies that design custom components, test production processes, or develop proprietary products
• Software and technology companies developing new applications, platforms, or tools
• Engineering and architecture firms that design and test new structural methods
• Food and beverage producers are developing new formulations or production processes.
• S Corporations in construction that develop specialized building techniques or materials

The key qualifying test is the four-part test under Section 41: the activity must be technological in nature, intended to discover information that eliminates technical uncertainty, experimental in its approach, and related to a qualified business component such as a product or process. Your qualification analysis for each prospect should walk through each prong of this test using specific examples from their business.

Reference IRS Publication 535 and the underlying Section 174 regulations when educating clients on the expense deductibility rules. Clients who see you cite authoritative sources respond with greater confidence and are more likely to engage your services.

How to structure your R&D credit sales conversation

The R&D credit sales conversation works best as a discovery session rather than a product pitch. Start by asking the prospect about their business operations in the past two to three years, specifically whether they invested in developing or improving any products, processes, or software. Most business owners will say yes to at least one of these categories.

1. Ask about specific development activities and identify any that involve technical uncertainty, experimentation, or process testing.
2. Estimate the associated wages, contractor costs, and supply expenses tied to those activities.
3. Calculate a rough credit range using the simplified credit calculation method, which applies 14% to qualified research expenses above a base amount.
4. Present the total available credit alongside the immediate deduction benefit for the 2026 domestic R&D expenses.
5. Discuss the retroactive relief opportunity if the client had capitalized domestic R&D costs during 2022 through 2024

This sequence produces a specific dollar estimate by the end of the conversation. That estimate is what closes the deal. Advisors who can walk a prospect through a preliminary credit calculation in a 30-minute meeting and produce a plausible range of $50,000 to $300,000 in available credits are almost always asked to proceed with a formal study.

How to handle the most common R&D credit objections

"We're not a tech company" is the most common objection, and it is easy to address with industry-specific examples. Ask the prospect whether they have ever spent money improving a manufacturing process, developing a new product variant, or testing a new approach to a recurring business challenge. Most will say yes, and that admission is all you need to demonstrate that their activities could qualify.

"It's too complicated, and the documentation requirements are too burdensome" is the second most common objection. Acknowledge that proper documentation is essential and then explain that your firm manages the documentation process as part of the engagement. The client's job is to participate in an interview and provide records they already have. Your job is to turn those records into a defensible credit study.

"We tried this before,e and it didn't work out" signals a prior negative experience, often with a firm that was aggressive in its credit calculations or did not prepare adequate documentation. Differentiate your approach by emphasizing conservative qualifications and audit-ready documentation. Reference IRS Publication 542 for corporate taxpayers and explain that your process follows published guidance rather than aggressive positions.

How to price and structure R&D credit engagements

R&D credit engagements are typically priced on a contingency basis as a percentage of the credit identified, on a fixed fee for the study and documentation, or on a hybrid that combines a modest fixed fee with a contingency component. Each model has advantages and disadvantages depending on your client relationship and risk tolerance.

Contingency pricing aligns your incentives with the client's and eliminates the upfront cost barrier. A standard contingency rate for a credit study is 15% to 25% of the credit identified, which is reasonable given the value delivered. For clients with C Corporations or Partnerships, who have different credit utilization rules, your pricing should account for the complexity of the entity structure in the credit calculation.

For clients who also qualify for retroactive relief under the OBBBA, the total fee scope expands to cover amended return preparation, which should be priced separately or as an add-on to the annual credit engagement. Multi-year retroactive claims are significant engagements that justify dedicated project pricing.

Connect R&D credit clients to your broader tax advisory services suite by explaining that R&D planning is most effective when it is coordinated with your entity structure, compensation design, and capital investment timing. Clients who engage your firm for R&D work are often excellent candidates for Late S Corporation elections or Depreciation and amortization strategy reviews as part of a comprehensive planning package.

How to build a scalable R&D credit advisory practice

A single R&D credit engagement is valuable. A practice built around recurring R&D credit work, where you manage documentation, claim credits annually, and coordinate with entity strategy, generates compound revenue from clients who need the service every year. Building that kind of recurring practice requires a documented delivery process and a client experience that makes annual renewal the path of least resistance.

Your tax advisory services R&D credit delivery process should begin each year with a documentation interview, typically 60 to 90 minutes with the client or their key technical personnel, that captures the specific research activities undertaken during the year. This interview follows a structured question guide that covers each qualifying criterion, the employees involved, the time allocation to qualifying activities, and the supply and contractor costs associated with each activity. Conducting this interview in a consistent, professional manner each year builds the client's confidence in your process and makes the documentation feel routine rather than burdensome.

After the interview, your process should produce a written R&D tax credit study that documents the qualifying activities, calculates the credit under the regular method or simplified credit method, and includes the supporting schedules required for the tax return. The study should be written in plain language that the client can understand, and it should explain the credit calculation without requiring a tax background to follow. Clients who receive a professionally written study each year view the engagement as a substantial deliverable, not just a line on their return.

Annual engagement letters that specify the scope of work, documentation requirements, and fee structure make the renewal conversation seamless. When a client knows each year what to expect, when to schedule the interview, and what the engagement will cost, they renew automatically rather than re-evaluating the relationship annually. This consistency is what transforms R&D credit work from a project-based service into a recurring revenue stream.

How to use OBBBA retroactive R&D relief for new deals

For clients who were subject to the five-year R&D amortization rules from 2022 through 2024, the retroactive relief pathway under the OBBBA represents an immediate, time-sensitive opportunity. These clients overpaid taxes in prior years on research costs they should have been able to deduct immediately, and they can now file to recover those overpayments. The urgency created by the refund statute of limitations, which generally limits claims to three years from the original filing date, makes this an excellent opening for immediate advisory engagement.

Your outreach to these clients should be specific about the opportunity. Identify clients who had significant domestic R&D spending in 2022, 2023, or 2024 from your prior year files. Calculate a rough estimate of the potential refund available from amending their returns to claim the retroactive deduction. Present that estimate in your outreach message as the specific financial reason for an immediate consultation.

For S Corporations and Partnerships that had R&D activities, the retroactive relief also involves amended K-1s to partners and shareholders, which creates additional work scope but also additional advisory value. Walking a Partnership client through the amended return process, the revised K-1s, and the individual partner-level refund implications demonstrates exactly the kind of comprehensive advisory coordination that compliance-only firms cannot provide.

The retroactive relief window is not permanent, and clients who delay beyond the statute of limitations permanently forfeit the opportunity. That genuine urgency, combined with a specific dollar estimate, makes retroactive R&D relief one of the most actionable advisory sales conversations available in 2026.

Scale your R&D advisory practice with Instead Pro

Instead's Pro partner program gives tax professionals the analytical tools to quickly identify R&D credit opportunities, calculate preliminary credit estimates, and document qualifying activities for client-ready presentations. Instead's intelligent system surfaces AI-driven R&D credit planning insights alongside other advisory strategies, allowing your firm to deliver comprehensive, coordinated advice rather than isolated credit studies. The Instead platform supports the documentation and reporting workflows that make R&D credit engagements efficient and scalable.

Explore the Instead Pro partner program to build your R&D credit advisory practice under the new 2026 OBBBA rules.

Frequently asked questions

Q: What did the OBBBA change about R&D expense deductibility?

A: The OBBBA restored immediate deductibility for domestic R&D expenses, reversing the capitalization and five-year amortization requirement that applied from 2022 through the effective date. Foreign R&D expenses still require 15-year amortization, but domestic research costs can once again be deducted in the year they are incurred.

Q: What industries commonly qualify for the R&D tax credit?

A: Manufacturing, software development, engineering, architecture, food production, and construction commonly produce qualifying R&D activities. The qualifying test focuses on whether the activity involves technological uncertainty, experimentation, and development of a qualified business component rather than on the industry itself.

Q: Can clients claim retroactive R&D expense deductions for 2022 through 2024?

A: Yes. The OBBBA includes a retroactive relief pathway under Revenue Procedure 2025-28 that allows qualifying small businesses to recover taxes paid on capitalized domestic R&D costs for tax years 2022 through 2024. The specific process varies by entity type and filing status.

Q: How do I price an R&D credit engagement?

A: Contingency pricing of 15% to 25% of the credit identified is common for credit study engagements. Fixed fee pricing is also appropriate for clients with well-defined research activities. Retroactive amended return work should be priced separately as a distinct engagement.

Q: How does R&D credit planning connect to other advisory services?

A: R&D credits interact with entity structure, compensation design, and capital investment timing. Clients with significant R&D activity often benefit from coordinated planning around S Corporation elections, depreciation strategy, and retirement plan contributions to maximize their overall tax position.